Session Synopses

Learn more.

Wright Center brandmark

Stay connected!


Networking Event (optional)

April 2, 2020
Thursday, 6-8 p.m. 
Optional registration fee: $10
Where: Hilton Richmond Hotel and Spa Short Pump

Virginia Clinical Research Conference

Includes lunch and beverage breaks

April 3, 2020
Friday, 7:30 a.m.-5 p.m.
Regular registration fee through March 3: $75.00
Where: Hilton Richmond Hotel and Spa Short Pump

Optional CEU and CME processing fees (at the time of registration)

Enroll now for April>

VCU/VCUHS employees are welcome to enter a VCU index code for payment on the registration page on the Invoice tab.

« Back to Virginia Clinical Research Conference

Keynote Speaker: Participant Perspective – Collaborating with the Clinical Research Study Team

Donna Cryer, JD, President and CEO of the Global Liver Institute

As a participant and patient advocate, and leader of a research network, Ms. Cryer will share her perspective on the importance of patient engagement in research highlighting participants as collaborators in the research process.  Ms. Cryer is a graduate of Harvard/Radcliffe Colleges and Georgetown University Law Center and serves on several boards including the People-Center Research Foundation and Sibley Memorial Hospital (Washington, DC). 

Session 1A: Collaborating to Bring Equitable Care to Communities: Transplantation/Gene Therapy

Facilitator: Wally Smith, MD, Vice Chair for Research, Division of General Internal Medicine; Virginia Commonwealth University

Dr. Smith returns to the conference to lead a session exploring issues including justice, access to care, cost, and the ethics of patient selection with a focus upon the transplantation/gene therapy research space. Together with the keynote speaker and expert panelists, this vibrant, interactive session will provide a format to involve all research team members in discussion.

Session 1B: Leveraging CTSAs to Promote Collaboration

Facilitators: Pablo Cure, MD, Program Director, Division of Clinical Innovation and Mary Purucker, MD, PhD, Director of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health

Dr. Pablo Cure and Dr. Mary Purucker will provide an overview of the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) Program, including NCATS priorities in translational science and opportunities to collaborate within the Program and beyond.

Session 1C: Investigational Pharmacists as Collaborators

Facilitators: Amy Adams, PharmD, CCRP, Lead Pharmacist, Investigational Drug Service; University of Virginia and Robin Sculthorpe, BS, RPh, Investigational Drug Services; VCUHealth

This session includes a presentation by Caroline D. Juran, RPh, DPh, Executive Director of the Virginia Board of Pharmacy discussing the Board’s perspective on Virginia laws and regulations which pertain to the management of investigational drugs in Virginia.   A question and answer period will provide an opportunity to interface with the Dr. Juran.  Additional conversation will cover areas where the Investigational Drug Pharmacist can work with IRBs, sponsors, investigators, nursing and other study team members for further development of IND submissions, overall procedures, protocols, randomizations, blinding techniques, inventory management and control to produce robust clinical data that allow new and innovative medications to reach those who need them.

Session 2A: Practicing Collaborations through Team Science

Facilitators: Catherine Bradshaw, PhD, MEd, Professor & Assoc. Dean for Research & Faculty Development, Curry School of Education, University of Virginia and Debbie Diaz-Granados, PhD, Director of Evaluation, Wright Center and Assistant Professor, School of Medicine, Virginia Commonwealth University

Developing effective collaborations to produce innovative and translational clinical research requires teamwork skills focused on coordinating work and integrating different perspectives. Evidence from the science of team science and the science of teams can inform how clinical research teams should function for optimal effectiveness. This session will focus on presenting evidence that attendees can apply in their respective teams. Small group activities and case studies will be used to provide attendees an interactive and dynamic session.

Session 2B: Overcoming Challenges in Inter-institutional Collaborations

Facilitator: Sandra Burks, RN, BSN, CCRC, Program Director, iTHRIV; University of Virginia

Clinical research projects which involve academic or university and community or regional health systems, public and private institutions, and/or diverse partnerships across Virginia may be challenging to structure but may also bring significant value for all.  This session will discuss some of these challenges related to contracting, compliance, and efforts to improve clinical research efficiency.

Session 2C: Collaborations Utilizing Biospecimens & Biorepositories

Facilitator: Christopher A. Moskaluk, MD, PhD, Professor and Walter Reed Chair of Pathology, Chairman, Dept. of Pathology; University of Virginia

Session panelists will give examples of collaborative human biospecimen programs that exist in Virginia institutions and discuss how regulations and institutional considerations affect these efforts. Topic areas include HIPAA, broad consent, and storage considerations among others.

Session 3A: Collaborative Lessons from the Crossroads (4x8x16)

Facilitator: Shirley Helm, MS, CCRP, Manager of Clinical Trial Administration, Wright Center; Virginia Commonwealth University

This session will highlight four (4) best practices, success stories, or challenges overcome regarding clinical research operations and management emphasizing collaborative efforts. Each presentation will have no more than eight (8) slides within a sixteen (16) minute segment. Panel and audience discussion to follow.

Session 3B: Community Engaged Study Collaborators

Facilitator: Alex Krist, MD, MPH, Professor, Department of Family Health; Virginia Commonwealth University

During this interactive session panelists will share their experiences with community engaged research, highlighting key principles of effective community engagement and the value research can bring to community stakeholders. Topics of discussion will include stakeholder involvement in research question development, how community members can develop relevant health messages for their community, helping communities use data to make better decisions, engaging communities to prevent youth exposure to violence, and engaging rural communities.

Session 3C: Data Sharing Collaborations:  Inter-institutional Considerations

Facilitator: Tamas Gal, PhD, Director of Research Informatics, Wright Center and Massey Cancer Center, Virginia Commonwealth University

This session will focus on the role of data sharing in current and future inter-institutional collaborations. The panelists will discuss non-profit and commercial data sharing models with special focus on the perceived and actual impact on patients. Audience participation in the discussion is emphasized.

Want to find out more? Get in touch.